Cryo-Cell International Inc (CCEL) stock
CCELNYSEServices-Misc Health & Allied Services, NECFiscal year ends November 30
$4.17−0.46 (-9.94%)
Close on Nov 18, 2026Market cap $33.62MP/E –Yield –
Cryo-Cell International gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
Cryo-Cell International's gross profit for the twelve months ending Aug 31, 2026 was $24.45M, down 0.1% year over year. For fiscal 2025 it was $24.19M, up 0.6% from the year before. Over ten years it grew 4.6% a year on average. The highest annual figure on record is $24.19M in fiscal 2025.
Annual gross profit
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Nov 30, 2025 | $24.19M | +0.6% |
| FY2024 | Nov 30, 2024 | $24.04M | +4.7% |
| FY2023 | Nov 30, 2023 | $22.95M | +6.5% |
| FY2022 | Nov 30, 2022 | $21.54M | +8.3% |
| FY2021 | Nov 30, 2021 | $19.90M | -7.4% |
| FY2020 | Nov 30, 2020 | $21.49M | -1.3% |
| FY2019 | Nov 30, 2019 | $21.78M | +5.3% |
| FY2018 | Nov 30, 2018 | $20.68M | +10.8% |
| FY2017 | Nov 30, 2017 | $18.66M | +7.5% |
| FY2016 | Nov 30, 2016 | $17.35M | +12.2% |
| FY2015 | Nov 30, 2015 | $15.46M | +6.7% |
| FY2014 | Nov 30, 2014 | $14.49M | +6.0% |
| FY2013 | Nov 30, 2013 | $13.67M | +4.5% |
| FY2012 | Nov 30, 2012 | $13.08M | -3.2% |
| FY2011 | Nov 30, 2011 | $13.52M | +2.0% |
| FY2010 | Nov 30, 2010 | $13.26M | – |
Quarterly gross profit
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026CQ3 2026 | Aug 31, 2026 | $6.21M | +3.1% |
| Q2 FY2026CQ2 2026 | May 31, 2026 | $6.10M | +0.4% |
| Q1 FY2026CQ1 2026 | Feb 28, 2026 | $6.03M | +0.7% |
| Q4 FY2025CQ4 2025 | Nov 30, 2025 | $6.11M | -4.4% |
| Q3 FY2025CQ3 2025 | Aug 31, 2025 | $6.02M | +1.4% |
| Q2 FY2025CQ2 2025 | May 31, 2025 | $6.07M | +0.9% |
| Q1 FY2025CQ1 2025 | Feb 28, 2025 | $5.98M | +3.4% |
| Q4 FY2024CQ4 2024 | Nov 30, 2024 | $6.39M | +9.1% |
| Q3 FY2024CQ3 2024 | Aug 31, 2024 | $5.94M | +4.0% |
| Q2 FY2024CQ2 2024 | May 31, 2024 | $6.02M | +6.9% |
| Q1 FY2024CQ1 2024 | Feb 29, 2024 | $5.79M | +0.5% |
| Q4 FY2023CQ4 2023 | Nov 30, 2023 | $5.85M | +4.0% |
| Q3 FY2023CQ3 2023 | Aug 31, 2023 | $5.71M | +7.2% |
| Q2 FY2023CQ2 2023 | May 31, 2023 | $5.63M | +3.6% |
| Q1 FY2023CQ1 2023 | Feb 28, 2023 | $5.76M | +11.7% |
| Q4 FY2022CQ4 2022 | Nov 30, 2022 | $5.63M | +12.1% |
| Q3 FY2022CQ3 2022 | Aug 31, 2022 | $5.33M | +5.7% |
| Q2 FY2022CQ2 2022 | May 31, 2022 | $5.43M | +9.0% |
| Q1 FY2022CQ1 2022 | Feb 28, 2022 | $5.16M | +6.3% |
| Q4 FY2021CQ4 2021 | Nov 30, 2021 | $5.02M | -4.0% |
| Q3 FY2021CQ3 2021 | Aug 31, 2021 | $5.04M | -12.3% |
| Q2 FY2021CQ2 2021 | May 31, 2021 | $4.98M | -7.6% |
| Q1 FY2021CQ1 2021 | Feb 28, 2021 | $4.85M | -5.3% |
| Q4 FY2020CQ4 2020 | Nov 30, 2020 | $5.23M | -7.0% |
| Q3 FY2020CQ3 2020 | Aug 31, 2020 | $5.75M | +2.1% |
| Q2 FY2020CQ2 2020 | May 31, 2020 | $5.39M | -2.0% |
| Q1 FY2020CQ1 2020 | Feb 29, 2020 | $5.12M | +1.8% |
| Q4 FY2019CQ4 2019 | Nov 30, 2019 | $5.62M | -5.1% |
| Q3 FY2019CQ3 2019 | Aug 31, 2019 | $5.63M | +4.6% |
| Q2 FY2019CQ2 2019 | May 31, 2019 | $5.50M | +15.8% |
| Q1 FY2019CQ1 2019 | Feb 28, 2019 | $5.03M | +8.7% |
| Q4 FY2018CQ4 2018 | Nov 30, 2018 | $5.92M | +22.4% |
| Q3 FY2018CQ3 2018 | Aug 31, 2018 | $5.39M | +9.5% |
| Q2 FY2018CQ2 2018 | May 31, 2018 | $4.75M | +2.2% |
| Q1 FY2018CQ1 2018 | Feb 28, 2018 | $4.63M | +8.6% |
| Q4 FY2017CQ4 2017 | Nov 30, 2017 | $4.84M | +9.2% |
| Q3 FY2017CQ3 2017 | Aug 31, 2017 | $4.92M | – |
| Q2 FY2017CQ2 2017 | May 31, 2017 | $4.64M | – |
| Q1 FY2017CQ1 2017 | Feb 28, 2017 | $4.26M | – |
| Q4 FY2016CQ4 2016 | Nov 30, 2016 | $4.43M | – |
See a number that looks wrong?